Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adma Biologics (ADMA) Total Current Liabilities (2016 - 2025)

Adma Biologics' Total Current Liabilities history spans 14 years, with the latest figure at $69.5 million for Q4 2025.

  • For Q4 2025, Total Current Liabilities rose 25.2% year-over-year to $69.5 million; the TTM value through Dec 2025 reached $69.5 million, up 25.2%, while the annual FY2025 figure was $69.5 million, 25.2% up from the prior year.
  • Total Current Liabilities reached $69.5 million in Q4 2025 per ADMA's latest filing, up from $56.5 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $74.9 million in Q2 2025 to a low of $18.2 million in Q2 2021.
  • Average Total Current Liabilities over 5 years is $43.4 million, with a median of $43.1 million recorded in 2023.
  • Peak YoY movement for Total Current Liabilities: surged 96.3% in 2021, then fell 5.85% in 2023.
  • A 5-year view of Total Current Liabilities shows it stood at $30.4 million in 2021, then grew by 29.26% to $39.3 million in 2022, then grew by 26.84% to $49.8 million in 2023, then rose by 11.52% to $55.5 million in 2024, then increased by 25.2% to $69.5 million in 2025.
  • Per Business Quant, the three most recent readings for ADMA's Total Current Liabilities are $69.5 million (Q4 2025), $56.5 million (Q3 2025), and $74.9 million (Q2 2025).